Back to search

France· FR:63678345

KIMMTRAK 100 microgrammes/0,5 mL, solution à diluer pour perfusion

A tebentafusp product containing tébentafusp, registered in France by IMMUNOCORE IRELAND (IRLANDE). The same ATC class is registered in 11 of our 19 countries.

ATC L01XX75

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedKIMMTRAK 100 microgrammes/0,5 mL, sol…ATCL01XX75REGISTER NO.FR:63678345PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Tebentafusp is registered in 11 of 19 countries.

Countries holding a registration under ATC L01XX75 (tebentafusp), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 7 of them publish a price we can compare per daily dose

Tebentafusp · ATC L01XX75

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tebentafusp costs, country by country.

Normalised to the WHO defined daily dose (9.7 mcg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Tebentafusp · price per daily dose (9.7 mcg)

USD · FX 28 Sept 2026

  • CH Switzerland$1341.35
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
TÉBENTAFUSP
Manufacturer
IMMUNOCORE IRELAND (IRLANDE)
Country
France (FR)
ATC code
L01XX75
ATC class
Tebentafusp
Defined daily dose
9.7 mcg, P
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400955089162
    1 flacon(s) en verre de 0,5 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tebentafusp in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tebentafusp products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Kimmtrak
  • Liechtenstein · Kimmtrak
  • Norway · Kimmtrak

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/06d00b36-e0d4-4fc4-a5e3-ca1c42a49110
GET /v1/drugs/06d00b36-e0d4-4fc4-a5e3-ca1c42a49110?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "63678345",
  "date_amm": "2022-04-01",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/22/1630",
  "substance": "TÉBENTAFUSP",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution à diluer pour perfusion",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Oui"
}

See everything about tebentafusp.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.